Logo image of OGI.CA

ORGANIGRAM GLOBAL INC (OGI.CA) Stock Fundamental Analysis

TSX:OGI - Toronto Stock Exchange - CA68617J1003 - Common Stock - Currency: CAD

1.59  +0.01 (+0.63%)

Fundamental Rating

2

OGI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 34 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of OGI have multiple concerns. OGI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OGI has reported negative net income.
OGI had a negative operating cash flow in the past year.
OGI had negative earnings in each of the past 5 years.
In the past 5 years OGI reported 4 times negative operating cash flow.
OGI.CA Yearly Net Income VS EBIT VS OCF VS FCFOGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.99%, OGI is in line with its industry, outperforming 55.88% of the companies in the same industry.
OGI has a Return On Equity (-16.27%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.99%
ROE -16.27%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI.CA Yearly ROA, ROE, ROICOGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

OGI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI.CA Yearly Profit, Operating, Gross MarginsOGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OGI has more shares outstanding
OGI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OGI has a worse debt to assets ratio.
OGI.CA Yearly Shares OutstandingOGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI.CA Yearly Total Debt VS Total AssetsOGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

OGI has an Altman-Z score of -0.91. This is a bad value and indicates that OGI is not financially healthy and even has some risk of bankruptcy.
OGI has a Altman-Z score of -0.91. This is comparable to the rest of the industry: OGI outperforms 44.12% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that OGI is not too dependend on debt financing.
OGI has a better Debt to Equity ratio (0.13) than 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -0.91
ROIC/WACCN/A
WACC8.25%
OGI.CA Yearly LT Debt VS Equity VS FCFOGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

OGI has a Current Ratio of 3.36. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
OGI has a better Current ratio (3.36) than 79.41% of its industry peers.
A Quick Ratio of 1.85 indicates that OGI should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.85, OGI is doing good in the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 1.85
OGI.CA Yearly Current Assets VS Current LiabilitesOGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.68% over the past year.
OGI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.33%.
OGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)83.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.07%
Revenue 1Y (TTM)7.33%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%17.21%

3.2 Future

OGI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.43% yearly.
The Revenue is expected to grow by 17.26% on average over the next years. This is quite good.
EPS Next Y49.21%
EPS Next 2Y38.52%
EPS Next 3Y29.86%
EPS Next 5Y20.43%
Revenue Next Year48.22%
Revenue Next 2Y31.13%
Revenue Next 3Y26.16%
Revenue Next 5Y17.26%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OGI.CA Yearly Revenue VS EstimatesOGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI.CA Yearly EPS VS EstimatesOGI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OGI. In the last year negative earnings were reported.
Also next year OGI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OGI.CA Price Earnings VS Forward Price EarningsOGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI.CA Per share dataOGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

OGI's earnings are expected to grow with 29.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.52%
EPS Next 3Y29.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

TSX:OGI (5/2/2025, 7:00:00 PM)

1.59

+0.01 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)05-12 2025-05-12
Inst Owners6.49%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap212.71M
Analysts77.78
Price Target2.89 (81.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-263.86%
Min EPS beat(2)-400%
Max EPS beat(2)-127.72%
EPS beat(4)1
Avg EPS beat(4)-141.69%
Min EPS beat(4)-400%
Max EPS beat(4)136.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-12.23%
Max Revenue beat(2)2.96%
Revenue beat(4)2
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)3.61%
Revenue beat(8)3
Avg Revenue beat(8)-3.83%
Revenue beat(12)5
Avg Revenue beat(12)-1.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)-13.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-125.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)37.98%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-4.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.28
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.24
BVpS2.42
TBVpS1.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.99%
ROE -16.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.13%
Cap/Sales 3.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.36
Quick Ratio 1.85
Altman-Z -0.91
F-Score2
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.07%
EPS Next Y49.21%
EPS Next 2Y38.52%
EPS Next 3Y29.86%
EPS Next 5Y20.43%
Revenue 1Y (TTM)7.33%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%17.21%
Revenue Next Year48.22%
Revenue Next 2Y31.13%
Revenue Next 3Y26.16%
Revenue Next 5Y17.26%
EBIT growth 1Y6.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.48%
EBIT Next 3Y48.57%
EBIT Next 5Y31.35%
FCF growth 1Y81.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.83%
OCF growth 3YN/A
OCF growth 5YN/A